Company intelligence / Profile preview
Verve Therapeutics
Cambridge, Massachusetts, United Statesvervetx.com ↗
- Ownership
- Public · VERV
- Employees
- ~500
- Development stage
- Phase 1
01
Overview
Verve Therapeutics has reported positive initial data from the Heart-2 Phase 1b trial of VERVE-102 targeting PCSK9 in HeFH and/or premature CAD patients. The treatment demonstrated a positive safety profile with no serious adverse events. Ongoing trials include Pulse-1 Phase 1b for VERVE-201 targeting ANGPTL3. The company expects further dose escalation data and an opt-in decision from Eli Lilly on its pipeline in H2 2025.
- Therapeutic areas
- Cardiovascular
- Modalities
- Gene editing (base editing)in vivo gene editing
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Eli Lilly & Co. (collaboration with opt-in rights on pipeline assets)Academic collaborations with leading research institutions are referenced but not specifically named.
04
Financials
- Market cap
- $994M
- Total revenue
- $33M
- Enterprise value
- $565.6M
Beyond the preview
Go deeper on Verve Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Verve Therapeutics.